Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Longitude Venture Partners Lp
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
10% Owner
Avg. Two Year Performance
(53%)
Avg. Purchase Return
(24%)
Compound
(45%)
Avg. Sale Return
(20%)
Compound
Holdings:
10.96M
shares
Last Three Months: 03-Feb-24 -- 02-May-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
03-May-22 -- 02-May-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions